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Primary effusion lymphoma (PEL) is caused by
Kaposi’s sarcoma-associated herpesvirus (KSHV)
and frequently also harbors Epstein-Barr virus
(EBV). The expression of KSHV- and EBV-encoded
microRNAs (miRNAs) in PELs suggests a role for
these miRNAs in latency and lymphomagenesis.
Using PAR-CLIP, a technology which allows the
direct and transcriptome-wide identification of
miRNA targets, we delineate the target sites for all
viral and cellular miRNAs expressed in PEL cell lines.
The resulting data set revealed that KSHV miRNAs
directly target more than 2000 cellular mRNAs,
including many involved in pathways relevant to
KSHV pathogenesis. Moreover, 58% of these
mRNAs are also targeted by EBV miRNAs, via
distinct binding sites. In addition to a known viral
analog of cellular miR-155, we show that KSHV
encodes a viral miRNA that mimics cellular miR-
142-3p function. In summary, this study identifies
an extensive list of KSHV miRNA targets, which are
likely to influence viral replication and pathogenesis.
INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV) is a human
g-herpesvirus that establishes latency in B lymphocytes and
causes primary effusion B cell lymphoma (PEL) (Carbone et al.,
2001; Cesarman et al., 1995). PEL-derived cell lines serve as
an important model system for KSHV latency and transforma-
tion. While most PELs are coinfected with the g-herpesvirus
Epstein-Barr virus (EBV) (Cesarman et al., 1995) and EBV infec-
tion has been linked to a number of B cell lymphomas, a role for
EBV in the lymphomagenesis of PELs has not been demon-
strated, and EBV is never found in PEL in the absence of KSHV.Cell Host &miRNAs are 22 nucleotide (nt) regulatory RNAs expressed
by animals, plants, and some viruses, particularly herpesviruses
(Gottwein and Cullen, 2008). With few exceptions, miRNA
biogenesis proceeds from pri-miRNA transcripts through a
pre-miRNA stem-loop intermediate to an imperfect 22 nt
RNA duplex. One strand of this duplex can be incorporated as
a mature miRNA in RNA-induced silencing complexes (RISCs).
The nonincorporated strand of the duplex is referred to as the
star strand and is degraded. Within RISC, miRNAs are bound
by Argonaute (Ago) proteins and induce the repression of
mRNAs bearing sequences with partial complementarity to the
miRNA. This effect is most commonly mediated through base
pairing between the ‘‘seed region’’ of the miRNA, spanning
nucleotides 2–7, and sites located in the 30UTRs of target
mRNAs (Bartel, 2009; Hafner et al., 2010).
During latency, KSHV expresses 12 pre-miRNAs, which are
processed to mature miRNAs called miR-K1 to miR-K12 (Gott-
wein and Cullen, 2008). The sequences of the KSHV miRNAs
are largely conserved between different KSHV isolates and
between PEL cell lines (Marshall et al., 2007). However, the
seed sequences of herpesviral miRNAs are generally not con-
served between herpesviruses that infect evolutionary distant
hosts. Consequently, the computational identification of viral
miRNA targets is challenging, and relatively few targets of
KSHV miRNAs have been identified.
Of likely relevance to KSHV-induced lymphomagenesis is
the finding that KSHV miR-K11 is a functional analog of cellular
miR-155, a consequence of the identical seed region of these
miRNAs (Gottwein et al., 2007; Skalsky et al., 2007). While stable
antagonism of miR-K11 did not reduce the growth or survival of
PEL cells under standard culture conditions (E.G. and B.R.C.,
unpublished data), a role for miR-K11 in KSHV-induced lympho-
magenesis in humans seems plausible in analogy to the reported
role of cellular miR-155 and a viral analog encoded by the
chicken herpesvirus Marek’s disease virus (MDV) in cellular
transformation and oncogenesis (Costinean et al., 2006; Linn-
staedt et al., 2010; O’Connell et al., 2008; Zhao et al., 2011).
A complete mechanistic understanding of the role of miR-155
and its analogs in cancer has remained elusive.Microbe 10, 515–526, November 17, 2011 ª2011 Elsevier Inc. 515
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PEL miRNA TargetomeSeveral cellular targets of KSHV miRNAs have been proposed
(Abend et al., 2010; Dolken et al., 2010; Gottwein and Cullen,
2010; Gottwein et al., 2007; Hansen et al., 2010; Lei et al.,
2010; Lu et al., 2010a, 2010b; Nachmani et al., 2009; Samols
et al., 2007; Skalsky et al., 2007; Ziegelbauer et al., 2009),
and biological consequences of target regulation have been
explored in some instances. Several KSHV miRNAs have also
been proposed to target viral mRNAs, including those encoding
RTA (ORF50), primase (ORF56), and MTA (ORF57) (Bellare and
Ganem, 2009; Lin and Ganem, 2011; Lu et al., 2010b). Functions
that have been attributed to KSHVmiRNAs include the regulation
of apoptosis (Abend et al., 2010; Ziegelbauer et al., 2009), tran-
scriptional reprogramming (Hansen et al., 2010), regulation of
epigenetic genome modification (Lu et al., 2010b), inhibition of
cell cycle arrest (Gottwein andCullen, 2010), changes in cytokine
expression (Abend et al., 2010), escape from natural killer cell
recognition (Nachmani et al., 2009), and regulation of the entry
into lytic KSHV replication (Bellare and Ganem, 2009; Lei et al.,
2010; Lu et al., 2010a, 2010b; Ziegelbauer et al., 2009).
The EBV genome contains two miRNA clusters. EBV-positive
PEL cell lines express mature miRNAs from all 22 pre-miRNAs of
the BART cluster, while BHRF1 miRNAs are not expressed (Cai
et al., 2006). The function of the BART miRNAs in PEL has not
been addressed, and only a few BART miRNA targets have
been proposed (Choy et al., 2008; Dolken et al., 2010; Lo
et al., 2007; Marquitz et al., 2011; Nachmani et al., 2009).
In addition to the work described above, the identification of
KSHV and EBV miRNA targets by Ago-2 immunoprecipitation
followed by the quantification of associated transcripts bymicro-
array analysis (RIP-CHIP) has been reported (Dolken et al.,
2010). In this work, 114 and 44 mRNAs were identified as candi-
date targets of the KSHV and EBV miRNAs, respectively, based
on increased association with Ago2 in cell lines expressing these
miRNAs compared to cell lines lacking KSHV and EBV miRNA
expression. While RIP-CHIP can serve as a measure for the
association of transcripts with Ago2, miRNA binding site predic-
tion from RIP-CHIP data has to consider the entire transcript,
and this technique therefore does not allow the direct identifica-
tion of either the targeting miRNA(s) or specific miRNA binding
sites. This is particularly limiting, given that miRNA-mediated re-
pression is often cooperative. This study also identified far fewer
mRNA targets than would be expected from the observation that
individual miRNAs can target hundreds of mRNAs (Bartel, 2009).
Here, we report the direct and transcriptome-wide identifica-
tion of miRNA binding sites in EBV-negative and EBV-positive
PEL cell lines using photoactivatable ribonucleoside-enhanced
crosslinking and immunoprecipitation (PAR-CLIP). To facilitate
accurate target site identification, we first established the
identity and sequence of all significantly expressed miRNAs by
Illumina Sequencing. PAR-CLIP analysis of PEL cell lines led
to the identification of hundreds of cellular binding sites for
KSHV and EBV miRNAs. This analysis also revealed that KSHV
miR-K10a partially mimics the activity of cellular miR-142-3p.
RESULTS
Small RNAs Expressed in PEL Cell Lines
We analyzed miRNA expression in the commonly used PEL cell
lines BC-1, BCBL-1, and BC-3 by deep sequencing. BC-1 cells516 Cell Host & Microbe 10, 515–526, November 17, 2011 ª2011 Elsare latently infected with both KSHV and EBV and express EBV
BART miRNAs in addition to KSHV miRNAs (Cai et al., 2006).
Since the majority of clinical cases of PEL are positive for both
KSHV and EBV (Cesarman et al., 1995), the coexpression of
KSHV miRNAs and EBV BART miRNAs is potentially relevant
to the pathogenesis of PEL. In contrast, BCBL-1 and BC-3 cells
are latently infected only with KSHV. While deep sequencing of
the KSHV miRNAs in the BCBL-1 and BC-3 cell lines has been
reported recently (Lin et al., 2010; Umbach and Cullen, 2010),
the small RNA composition of BC-1 cells has so far only been
analyzed by low-throughput sequencing (Cai et al., 2005).
Small RNAs between 18 and 25 nt were used for cDNA
library construction and sequenced on the Illumina GAII
platform. The genomic origin of aligned small RNA reads is pre-
sented in Figures 1A–1C and Table S1 (see online). As previously
reported (Umbach and Cullen, 2010), we observed that the
majority (i.e., 83%) of miRNA reads in BC-3 cells were of
KSHV origin. In contrast, the percentages of KSHVmiRNA reads
obtained from BCBL-1 and BC-1 cell lines were much lower
(30% and 27% of miRNA reads, respectively). We were
able to validate higher expression of a subset of KSHV miRNAs
as well as lower expression of the cellular miRNAmiR-16 in BC-3
cells using primer extension analysis (Figures 1D and 4A).
The relative abundance of KSHVmiRNA reads differed slightly
between this manuscript and the data reported previously for
BC-3 (Umbach and Cullen, 2010) and more substantially from
those reported for BCBL-1 (Lin et al., 2010). Absolute read
numbers were therefore only cautiously interpreted as indicators
of the expression level for each miRNA. Nevertheless, this data
set identifies the precise sequence of all significantly expressed
viral and cellular miRNAs in these cell lines. In addition, several
other findings obtained from this data set are pointed out below.
KSHV miRNAs
Significantly expressed miRNAs of KSHV origin are summarized
in Table 1. KSHV miRNAs were recovered at substantially
different frequencies in the same cell line, and frequencies of
individual miRNAs also differed between cell lines. Primer
extension analysis of miR-K3, miR-K8-3p, and miR-K10 expres-
sion in an extended set of PEL cell lines confirmed that the
expression of these miRNAs differs substantially between cell
lines (Figure 1D). We and others detected KSHV miRNA
sequences derived from both arms of most of the 12 KSHV
pre-miRNAs (Table 1) (Lin et al., 2010; Umbach and Cullen,
2010). Our data set also confirmed the absence of miR-K9 in
BC-3 cells (Umbach and Cullen, 2010).
As reported (Umbach and Cullen, 2010), the 50 termini of the
mature KSHV miRNAs were mostly uniform, with some notable
exceptions (Table 1). Specifically, we confirmed the presence
of four distinct seed sequences of miR-K10-3p, as reported
previously for BC-3 (Umbach and Cullen, 2010), in all three cell
lines. Seed variation of miR-K10-3p is due to differential pro-
cessing and adenosine (A) to inosine (I) editing within the seed
of both 50-processing variants of miR-K10 (Pfeffer et al., 2005;
Umbach and Cullen, 2010). By primer extension analysis, we
confirmed that miR-K10 has two different 50 ends in a panel of
seven PEL cell lines (Figure 1D). Interestingly, BC-1 libraries,
but not BCBL-1 and BC-3 libraries, also contained a novel 50
seed variant of miR-K3, in addition to the variant shared withevier Inc.
Figure 1. Small RNA Sequencing
(A–C) Genomic location of aligned small RNA
reads. For a detailed breakdown, see Table S1.
(D) Primer extension analysis of miRNA expression
in an extended set of PEL cell lines. miR-K10a was
easily detected in BC-1 and JSC-1 cells upon
longer exposure (data not shown).
(E) Alignment of miR-K10a and miR-142-3p
sequences. /+1_5 indicates a 50 terminal offset
from the miRBase sequence by 1 nt. The seed
sequence of miR-K10a is also identical to that
of rhesus lymphocryptovirus miR-rR1-15-3p
(Umbach et al., 2010).
(F and G) (F) Primer extension analysis of miR-
142-3p in BC-3 cells and the murine B cells line
S11. 293T was used as a negative control (G)
primer extension analysis of miR-142-3p expres-
sion (top panel) in BJAB, BC-3, and lymphatic
endothelial cells (LEC). 5S RNA served as loading
control. See also Tables S1–S4.
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PEL miRNA TargetomeBC-3 and BCBL-1 (Table 1). Using primer extension analysis, we
detected expression of miR-K3_+1_5 in BC-1 cells and, surpris-
ingly, also in two other PEL cell lines (Figure 1D). It remains to be
addressed whether differences in miR-K3 processing between
PEL cell lines reflect genomic sequence polymorphisms. Signif-
icant A to I editing of viral miRNAs other than miR-K10 were not
observed (data not shown), and the presence of previously
reported low abundance small RNAs was not analyzed due to
the limited sequencing depth of the data set (Lin et al., 2010;
Umbach and Cullen, 2010).
We and others have previously shown that miR-K11 shares
a seed region with miR-155, resulting in regulation of an overlap-
ping set of target mRNAs by these two miRNAs (Gottwein et al.,
2007; Skalsky et al., 2007). Interestingly, miR-K10a_+1_5 has
a 7-mer seed region identical to that of cellular miRNA miR-
142-3p_1_5, whose sequence differed by one 50-terminal
nucleotide from that reported in miR-base (v16) (Figure 1E)
(Griffiths-Jones et al., 2006; Wu et al., 2009). Using primer exten-
sion analysis, we confirmed the expression of miR-142-3p and
miR-142-3p_1_5 in a panel of PEL cell lines (Figure 1D). While
pri-miR-142-3p has been reported to undergo A to I editing
within the miRNA stem loop (Yang et al., 2006), we did not detect
editing of mature miR-142-3p in our libraries (data not shown),
despite high numbers of miR-142-3p reads. The detection of
identical 50 variants of miR-142-3p in the murine B cell line S11
(Figure 1F) indicated that the seeds of both miR-142-3p 50 vari-
ants are evolutionary conserved and therefore likely important
for miR-142-3p function.
The expression of miR-142-3p is restricted to hematopoietic
cells, and overexpression of miR-142 in murine hematopoietic
progenitor cells enhances T cell differentiation in vitro (Chen
et al., 2004). Targets and specific functions of miR-142-3p,
however, remain largely unexplored. The expression patternCell Host & Microbe 10, 515–526, Nof miR-142-3p suggests that miR-
K10a_+1_5 may be redundant with
miR-142-3p_1_5 in B cells. Because
KSHV also causes Kaposi’s sarcoma,
a tumor driven by KSHV-infected endo-thelial cells, we tested whether miR-142-3p is expressed in
primary human lymphatic endothelial cells (LECs). Expression
of miR-142-3p in LECs was not detectable by either primer
extension analysis (Figure 1G) or Illumina Sequencing (data not
shown), suggesting that miR-K10a_+1_5 is not redundant with
miR-142-3p expression in endothelial cells, a cell type relevant
to the biology and pathogenesis of KSHV. Using the miRNA
sequencing data described above and miRBase (v16), we iden-
tified several other KSHV miRNAs with potential cellular analogs
(Table S2).
EBV and Cellular miRNA Expression Profile
Consistent with previous reports (Cai et al., 2006; Grundhoff
et al., 2006; Pfeffer et al., 2004), we detected mature miRNAs
derived from all known BART pre-miRNAs but no mature
BHRF1 miRNAs in BC-1 cells (Table S3). While the EBV BART-
miRNAs together accounted for only 13% of the miRNA reads
in BC-1, reads for some individual EBV miRNAs were abundant,
with BART-16-5p, miR-BART-22, and miR-BART-6-3p together
accounting for 56% of the EBV miRNA reads. Candidates
for cellular analogs of the EBV BART miRNAs have been listed
previously (Chen et al., 2010). All three PEL cell lines showed
high expression of several cellular miRNAs, despite the overall
lower expression of cellular miRNAs in BC-3 cells. Cellular
miRNA seed sequences that were among the top 15 most
abundant cellular seed sequences in all three libraries are listed
in Table S4.
PAR-CLIP
We selected BC-1 and BC-3 cells for the identification of
miRNA binding sites using PAR-CLIP, a technology that allows
the transcriptome-wide identification of miRNA target sites,
when applied to Ago proteins (Hafner et al., 2010). Briefly, PELovember 17, 2011 ª2011 Elsevier Inc. 517
Table 1. KSHV miRNA Expression Profile in PEL Cell Lines
BC1 BC3 BCBL1
miRNA Arm Sequence Count
Percentage
of Total
Percentage
of KSHV Count
Percentage
of Total
Percentage
of KSHV Count
Percentage
of Total
Percentage
of KSHV
miR-K1-star 3p GCAGCACCTGTTTCCTGCAACC 27 0.00% 0.01% 449 0.01% 0.01% 72 0.00% 0.01%
miR-K1 5p ATTACAGGAAACTGGGTGTAAG(CTG) 12,151 0.97% 3.57% 64,825 1.64% 1.96% 57,761 1.32% 4.26%
miR-K2-star 3p GATCTTCCAGGGCTAGAGCTG 250 0.02% 0.07% 659 0.02% 0.02% 309 0.01% 0.02%
miR-K2 5p AACTGTAGTCCGGGTCGAT(CTGA) 5,862 0.47% 1.72% 47,772 1.21% 1.45% 37,418 0.85% 2.76%
miR-K3-star 3p TCGCGGTCACAGAATGTGACA 31 0.00% 0.01% 201 0.01% 0.01% 201 0.00% 0.01%
miR-K3 5p TCACATTCTGAGGACGGCAGCGA(CG) 4,034 0.32% 1.19% 5,546 0.14% 0.17% 5,546 0.13% 0.41%
miR-
K3_+1_5
5p ATCACATTCTGAGGACGGCAGCGA 1,163 0.09% 0.34% NA NA NA NA NA NA
miR-K4-3p 3p TAGAATACTGAGGCCTAGCTG(A) 40,506 3.22% 11.91% 1,093,017 27.62% 33.09% 309,943 7.06% 22.84%
miR-K4-5p 5p AGCTAAACCGCAGTACTCTAGG 340 0.03% 0.10% 13,072 0.33% 0.40% 14,667 0.33% 1.08%
miR-K5 3p TAGGATGCCTGGAACTTGCCGG(T) 34,494 2.74% 10.15% 18,391 0.46% 0.56% 11,647 0.27% 0.86%
miR-K6-3p 3p TGATGGTTTTCGGGCTGTTGAG(C) 133,588 10.63% 39.29% 668,532 16.90% 20.24% 584,933 13.33% 43.10%
miR-K6-5p 5p CCAGCAGCACCTAATCCATCGG 723 0.06% 0.21% 22,725 0.57% 0.69% 795 0.02% 0.06%
miR-K7 3p TGATCCCATGTTGCTGGCGC(TCA) 10,806 0.86% 3.18% 194,585 4.92% 5.89% 128,153 2.92% 9.44%
miR-K7-star 5p AGCGCCACCGGACGGGGATTTATG 218 0.02% 0.06% 6,260 0.16% 0.19% 859 0.02% 0.06%
miR-K8 3p CTAGGCGCGACTGAGAGAGC(AC) 38,752 3.08% 11.40% 204,612 5.17% 6.19% 24,851 0.57% 1.83%
miR-K8-star 5p ACTCCCTCACTAACGCCCCGCT 230 0.02% 0.07% 5,312 0.13% 0.16% 336 0.01% 0.02%
miR-K9 3p CTGGGTATACGCAGCTGCGT(AA) 286 0.02% 0.08% NA NA NA 242 0.01% 0.02%
miR-K9-star 5p ACCCAGCTGCGTAAACCCCG(CT) 305 0.02% 0.09% NA NA NA 793 0.02% 0.06%
miR-K10a 3p TAGTGTTGTCCCCCCGAGTGG(C) 283 0.02% 0.08% 11,156 0.28% 0.34% 7,908 0.18% 0.58%
miR-K10b 3p TGGTGTTGTCCCCCCGAGTGG(C) 30 0.00% 0.01% 697 0.02% 0.02% 467 0.01% 0.03%
miR-
K10a_+1_5
3p TTAGTGTTGTCCCCCCGAGTGG(C) 92 0.01% 0.03% 6,461 0.16% 0.20% 4,539 0.10% 0.33%
miR-
K10b_+1_5
3p TTGGTGTTGTCCCCCCGAGTGG(C) 28 0.00% 0.01% 713 0.02% 0.02% 398 0.01% 0.03%
miR-K10-
star
5p GGCTTGGGGCGATACCACCACT NA NA NA 341 0.01% 0.01% 1,175 0.03% 0.09%
miR-K11 3p TTAATGCTTAGCCTGTGTCCG(AT) 4,124 0.33% 1.21% 101,848 2.57% 3.08% 56,219 1.28% 4.14%
miR-K11-
star
5p GGTCACAGCTTAAACATTTCTAGG 18 0.00% 0.01% 546 0.01% 0.02% 1,106 0.03% 0.08%
miR-K12-
star
3p TGGGGGAGGGTGCCCTGGTTG(A) 233 0.02% 0.07% 79,473 2.01% 2.41% 17,691 0.40% 1.30%
miR-K12 5p AACCAGGCCACCATTCCTCTCCG 3 0.00% 0.00% 823 0.02% 0.02% 776 0.02% 0.06%
Significantly expressed KSHV miRNAs. Columns identify the miRNA name, which arm of the precursor the miRNA sequence is derived from, miRNA sequence, read counts, and the percentage of
total or KSHV miRNA reads these reads represented. /+1_5 indicates a 50-terminal offset from the miRBase sequence by 1 nt. Nucleotides in brackets were not present in all reads considered.
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Figure 2. Computational Analysis of PAR-CLIP Data
(A) Flowchart outlining the computational pipeline used for PAR-CLIP analysis.
(B) Example of PARalyzer cluster identification. A BC-1-derived cluster
mapping to the 30UTRof RFXAPwith a seedmatch tomiR-K1 is shown. Shown
are read depth (gray) and the distributions of T to C conversions (red, signal)
and nonconverted Ts (blue, noise). The seed match to miR-K1 is highlighted.
This seed match is validated further below.
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PEL miRNA Targetomecells were incubated with the photoactivatable ribonucleoside
4-thiouridine (4SU), which is incorporated into newly synthesized
RNAs. Cells were UV irradiated at 365 nm, which efficiently
crosslinks 4SU to associated RNA binding proteins (Hafner
et al., 2010). Cells were then lysed and immunoprecipitated for
endogenous Ago2. Other Ago proteins were not included,
because indistinguishable results have been obtained previously
for the analysis of different Ago proteins (Hafner et al., 2010).
Immunoprecipitates were digested with RNaseT1, protected
RNAs were radiolabeled, and Ago2-RNA complexes were puri-
fied by SDS-PAGE. Associated RNA fragments were recovered
and processed for Illumina Sequencing. Due to altered base-
pairing properties of formerly crosslinked 4SU bases, resulting
libraries contain thymidine (T) to cytidine (C) conversions at
crosslinking sites, thereby distinguishing signal from noise
(Hafner et al., 2010). Crosslinking is not observed in regions
that undergo perfect base pairing to the miRNA seed, and T to
C conversions are typically observed 50 of the miRNA seed
match (Hafner et al., 2010).
Reads obtained for each library were analyzed using mapping
and clustering strategies described in Figure 2 and the Supple-
mental Experimental Procedures. We obtained 12,887,172
reads for BC-1 cells and 14,029,755 reads for BC-3 cells,
40% (BC-1) and 26% (BC-3) of which mapped to the human
or viral genomes at a single location. Seventy-five percent (BC-1)
and 49% (BC-3) of aligned reads had T to C conversions. WeCell Host &used the PARalyzer toolkit to identify Ago2 binding sites (Cor-
coran et al., 2011). Reads that overlapped by at least 1 nt were
grouped together. Next, clusters were generated based on the
distributions of T to C transitions (signal) and nonconverted Ts
(noise) as well as read depth. This approach results in clusters
that are smaller and consequently allows for higher resolution
of closely spaced binding sites compared to the approach
reported previously (Hafner et al., 2010). The breakdown of the
resulting clusters is presented in Figure 3A and Table S5. Clus-
ters were most frequently located in 30UTR regions (37% for
BC-1 and 29% for BC-3 cells) and intergenic regions (30% in
BC-1 and 39% in BC-3 cells). A smaller percentage of clusters
mapped to coding regions and introns. When we required T to
C conversion events at more than one location within clusters
and excluded clusters mapping to repeats, the percentage of
clusters in 30UTRs and in coding regions increased (Figure 3A).
In contrast, clusters in intergenic and intronic regions of the
genome became less frequent. Together, these observations
confirm that miRNA binding sites are preferentially located in
30UTRs and indicate that at least a subset of intronic and inter-
genic clusters likely represent transient interactions that are
captured by PAR-CLIP.
Finally, we examined clusters for the presence of canonical
seed matches to all miRNAs that are significantly expressed in
the matched small RNA libraries described above. The minimal
seed matches considered were ‘‘7mer1A’’ and ‘‘7mer2-8’’
matches (Bartel, 2009). Clusters with seed matches to ex-
pressed miRNAs were considered candidate target sites. Of
the clusters mapping to human 30UTRs, 69% (BC-1) and 70%
(BC-3) had seedmatches to expressedmiRNAs (Table S6). Simi-
larly, 65% (BC-1 and BC-3) of clusters that mapped to human
coding regions had seed matches to expressed miRNAs. Of
note, assignment of the targeting miRNA is sometimes not
entirely unambiguous, when clusters contain matches to more
than one miRNA or for miRNAs with seed homology. Our unre-
lated work using WT and miRNA mutant EBV allowed us to
estimate the rate of incorrect assignment to be %15% (R.L.S.,
D.L.C., E.G., C.L. Frank, M.H., J.D.N., R. Feederle, H.J. Dele-
cluse, M. Luftig, T.T., U.O., and B.R.C., unpublished data; and
Supplemental Discussion).
To address the overlap in candidate targets between the two
libraries, we compared human candidate 30UTR targets of
KSHV miRNAs expressed in both cell lines. We restricted this
analysis to 30UTRs, because recent publications suggest that
miRNA binding sites located in 30UTRs result in greater target
inhibition than those located in coding regions (Gu et al., 2009;
Hafner et al., 2010). We identified 1741 candidate target mRNAs
of the KSHV miRNAs in BC-1 cells and 1409 candidate target
mRNAs in BC-3 cells, with 60% of the BC-1 sites and 75%
of the BC-3 sites detected in both libraries (Figure 3B). To
address whether the overlap between the two libraries may
be limited primarily by library depth rather than biological
differences, we plotted read numbers for clusters with KSHV
miRNA seed matches from BC-1 and superimposed clusters
that were also recovered fromBC-3 cells (Figure 3C). It is evident
that sites detected in one library were typically also recovered in
the other library if they had higher read numbers, while overlap
was more limited for sites with lower read depth. The same
was true for targets found in BC-3 (Figure 3D). Therefore, limitedMicrobe 10, 515–526, November 17, 2011 ª2011 Elsevier Inc. 519
Figure 3. Characteristics of BC-1 and BC-3
PAR-CLIP Libraries
(A) Location of PAR-CLIP clusters within the
human genome. For ‘‘2TC, no repeats,’’ only
clusters not mapping to repeats and with T to C
conversions atR2 locations were analyzed.
(B) Venn diagram showing the overlap of mRNAs
with 30UTR sites for KSHV miRNAs between BC-1
and BC-3 libraries. Only KSHVmiRNAs expressed
in both cell lines were considered.
(C) Read depth for KSHV miRNA targets sites
found in BC-1 (white), read depth for the subset of
these clusters that were also recovered in BC-3
with R1 (green) or R2 (red) locations with T to C
conversions.
(D) As in (C), except that sites from BC-3 are in
white, and the sites that are also recovered in
BC-1 are in green and red. See also Table S5 and
Table S6.
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PEL miRNA Targetomelibrary depth may at least partially account for the incomplete
overlap between KSHV miRNA target sites recovered from
both cell lines.
Many Published miRNA Targets Are Confirmed
by PAR-CLIP
To confirm that the PAR-CLIP libraries correctly identifiedmiRNA
targets, we took advantage of our previous finding that miR-K11
is a functional analog of cellular miR-155 (Gottwein et al., 2007;
Skalsky et al., 2007). To date, 153 30UTR targets of miR-155
have been validated minimally using 30UTR indicator assays
(Table S7). Of these, 121 were expressed in BC-1 and/or BC-3
cells based on published (Fan et al., 2005) and/or newly gener-
ated microarray data (Table S7 and Table S8). Forty-seven of
these 121 mRNAs were identified as targets for miR-K11 in at
least one of the PAR-CLIP libraries. In cases in which these
targets were also predicted as targets of miR-155 by TargetScan
(Grimson et al., 2007), PAR-CLIP identified the conserved site(s)
of interaction. In addition, PAR-CLIP identified >300 mRNAs
as candidate targets of miR-K11 that have not previously been
reported to be targets of miR-155 or miR-K11. Despite the large
number of miR-K11 targets recovered,70 previously proposed
targets of miR-155 with expression in BC-1 and BC-3 were not
confirmed as targets of miR-K11 by PAR-CLIP. These mRNAs
may (1) be targets of miR-155 in other settings, but not targets
of miR-K11 in PEL; (2) may have been missed in our analysis,
for example due to limitations in library depth; or (3) may not be
authentic miR-155/miR-K11 targets. Nevertheless, the recovery
of 40% of the reported miR-155 targets strongly suggests
that these libraries correctly identify many valid miRNA targets.520 Cell Host & Microbe 10, 515–526, November 17, 2011 ª2011 Elsevier Inc.Our data set also confirmed 12 out
of 29 validated KSHV miRNA targets
with expression in our data set (>40%).
Confirmed interactions include those
with BACH1, FOS, CDKN1A (p21),
TNFRSF12A (TWEAKR), RAD21, and
RBL2 mRNAs, whose regulation had
previously been validated at the level of
protein expression (Abend et al., 2010;Gottwein and Cullen, 2010; Gottwein et al., 2007; Li et al.,
2009; Lu et al., 2010b). A list summarizing the recovery of
previously published targets of the KSHV and EBV miRNAs
is presented in Table S9. This table also includes a compar-
ison with the data set published by Do¨lken et al. (Dolken
et al., 2010), which is further discussed in the Supplemental
Discussion.
PAR-CLIP Targets of KSHV miRNAs Are Downregulated
at the mRNA Level
miRNA-mediated regulation often leads to a drop in mRNA
expression (Lim et al., 2005). We therefore investigated whether
PAR-CLIP targets were downregulated in microarray data
from KSHV-negative B cell pools individually expressing physio-
logical levels of miR-K1, miR-K4-3p, and miR-K11 (Gottwein
et al., 2007 and Figure 4A). In addition to the reported compre-
hensive validation of the array data for miR-K11 (Gottwein
et al., 2007), we confirmed that changes in mRNA expression
corresponded to changes in protein levels for two candidate
targets of the KSHV miRNAs: tumor protein D52 (TPD52) was
identified as a candidate target for miR-K4-3p and miR-K11 by
PAR-CLIP, but its regulation in the microarray data was statisti-
cally significant only for miR-K4-3p. As anticipated, TPD52 was
downregulated at the protein level by miR-K4-3p (Figure 4B).
TPD52 expression was also lower in cells expressing miR-K11,
suggesting that PAR-CLIP correctly identified TPD52 as a target
of miR-K11. The catalytic subunit of protein phosphatase
2A (PPP2CA) was identified as a target for miR-K1 by both
PAR-CLIP and microarray analysis and was also regulated by
miR-K1 at the protein level (Figure 4B).
Figure 4. PAR-CLIP Targets of KSHV miRNAs Are Downregulated at the mRNA Level
(A) Primer extension analysis of BJAB cell pools stably expressing KSHV miR-K1 (upper) or miR-K4-3p (lower). miR-16 served as a loading control.
(B) Western blot analysis of TPD52 and PPP2CA expression in untransduced BJAB cells and transductants stably expressing the control vector or the indicated
miRNA. GAPDH expression served as loading control.
(C) Normalized enrichment scores (NES) and FDR q values for the enrichment of PAR-CLIP targets of the indicated miRNA from BC-1 or BC-3 libraries in the
corresponding microarray data. Also shown are data for the enrichment of either 7mer1A or 7mer2-8 seed matches in the array data.
(D) Gene set enrichment plots showing the enrichment of PAR targets of the indicated miRNA from BC-1 or BC-3 libraries in the corresponding rank-ordered
gene lists. See also Table S10.
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nian et al., 2005) to analyze the distribution of PAR-CLIP 30UTR
targets of miR-K1, miR-K4-3p, and miR-K11 in the microarray-
derived rank-ordered gene lists (Figures 4C and 4D). Importantly,
PAR-CLIP targets were significantly enriched among downregu-
lated genes. In contrast, enrichments of candidate targets pre-
dicted by seed matching alone were not statistically significant
when the entire gene list was considered (Figures 4C and 4D).
Thus, PAR-CLIP clearly outperformed seed matching in the
prediction of functional miRNA targets from microarray data,
despite the fact that PAR-CLIP targets were derived from unre-
lated B cell lines. PAR-CLIP-derived targets that contributed to
these enrichments are listed in Table S10.
PAR-CLIP Successfully Identifies KSHV miRNA Targets
The data described above strongly suggests that PAR-CLIP
identified functional targets of the KSHVmiRNAs.We next asked
whether PAR-CLIP-identified 30UTR target interactions could be
validated using 30UTR indicator assays.We focused this analysis
mostly on 30UTRs of mRNAs encoding proteins with functions of
potential relevance to KSHV biology and pathogenesis (Table
S11). Thirty-six combinations of 30UTR indicators and KSHV
miRNAs with PAR-CLIP interactions were tested for regulation.
Nine of these interactions were independently also predicted
by microarray analysis of the BJAB cell pools expressing miR-
K1, miR-K4-3p, or miR-K11 described above (i.e., for miR-K1,
NMI, RAD21, BCL11A, RFXAP; for miR-K4-3p, TPD52, GRB2,
MCC, YWHAB; for miR-K11: WEE1). Targets were representa-
tive of the full range of seedmatch types observed in the libraries
(Table S6 and Table S11).
Resulting data are summarized as a heat map in Figure 5A and
presented as individual bargraphs in Figure S1. Expression
controls for the KSHV miRNAs are also presented in Figure S1.
Of the 36 miRNA-30UTR pairs, 28 showed significant downregu-
lation of 30UTR indicator activity, i.e., >77% of PAR-CLIP pre-
dicted target sites could be validated as regulatory interactions
using this assay. Validated interactions included several targets
with minimal seed base pairing (NMI, CSNK1A1), several targets
that were detected by PAR-CLIP in only one library, targets with
ambiguous seedmatch assignment (e.g., ZFYVE9, miR-K9), and
also targets with only one location of T to C conversion events in
the relevant cluster (BCL11A, SOS1, WEE1), suggesting that
these criteria do not necessary limit successful target validation.
Eight 30UTR-miRNA combinations did not respond as expected
(green boxes in Figure 5A, Figure S1). Potential reasons for the
observed lack of regulation are discussed in the Supplemental
Discussion.
We next sought to determine if targets of miR-K10a are shared
by miR-142-3p, as predicted from the identical seed sequences
of miR-K10_+1_5 and miR-142-3p_1_5. We tested nine
30UTR indicator vectors with PAR-CLIP-predicted 30UTR targets
for miR-K10a_+1_5p and miR-142-3p_1_5 for regulation by
miR-142 (Figures 5D–5H). For eight of nine 30UTRs tested,
expression of miR-K10 and miR-142 resulted in similar levels
of downregulation of indicator activity, suggesting that these
two miRNAs do indeed share targets, as predicted by their
seed homology and PAR-CLIP analysis. The 30UTR indicator
vector for SLA did not respond significantly to either miR-K10
or miR-142-3p expression (Figures 5A and 5H). To test whether522 Cell Host & Microbe 10, 515–526, November 17, 2011 ª2011 ElsPAR-CLIP indeed correctly identified miRNA binding sites, we
introduced 2 nt seed mutations into nine PAR-CLIP-predicted
binding sites. To further strengthen the point that miR-K10a
and miR-142-3p indeed act through the same binding sites,
seven of these were predicted to be targeted by miR-K10a/
miR-142-3p. In all cases in which miRNA expression resulted
in significant downregulation of indicator expression, seed
mutation rescued indicator expression (Figures 5B–5G), further
demonstrating that PAR-CLIP indeed correctly identified
the site(s) of interaction. In addition, these experiments also
demonstrate that KSHV encodes at least two functional mimics
of cellular miRNAs expressed in hematopoietic cells, i.e., miR-
142-3p_1_5 and miR-155.
While more experiments will be required to elucidate func-
tional differences between miR-K10a and miR-142-3p, it is rele-
vant to point out that, because the first nucleotide of miR-K10a
is a uridine, 7mer1A matches to miR-K10a are also 7mer2-8
matches to miR-K10a_+1_5/miR-142-3p_1_5. Consequently,
only 15% of the PAR-CLIP-predicted targets for both miR-
K10a 50 seed variants are predicted to be unique targets of
miR-K10a (Figure 5I). We therefore anticipate that, together,
the two seed variants of miR-K10a effectively mimic miR-142-
3p_1_5. In contrast, less than 30% of the PAR-CLIP-predicted
targets for both miR-142-3p variants are common to both seed
variants of this miRNA (Figure 5I).
Properties of the KSHV miRNA Targets
To predict which cellular pathways are likely to be regulated
by KSHV miRNAs, we tested whether PAR-CLIP targets of
the KSHV miRNAs are enriched in specific cellular pathways
with ‘‘Gene Ontology (GO) FAT’’ terms using DAVID (Huang da
et al., 2009). A small subset of pathways with significant enrich-
ment of KSHV miRNA candidate targets is listed in Figure 6A.
The complete list of pathways with significant enrichments can
be found in Table S12A. Based on the large number of KSHV
miRNA targets and the fact that we find significant enrichments
in multiple cellular pathways, it is evident that the KSHV miRNAs
together serve many different functions. KSHV miRNA targets
were especially enriched for transcriptional activators and
repressors, proteins with roles in signal transduction, and protein
and vesicular trafficking.
We next conducted a similar analysis for 30UTR targets of the
EBV BART miRNAs. A small subset of overrepresented terms is
shown in Figure 6B, and the full set of terms with enrichments
and associated target mRNAs is presented in Table S12B. Inter-
estingly, many of the pathways with enrichments overlapped
with those targeted by the KSHV miRNAs, suggesting functional
similarities between the KSHV and EBV miRNAs. This finding
prompted us to investigate the overlap between cellular targets
of the KSHV miRNAs and the EBV miRNAs. Fifty-eight percent
of the 30UTR targets of KSHV miRNAs also had clusters with
seed matches to EBV BART miRNAs. This distribution is very
unlikely to be due to chance (p < 108). This was estimated by
random sampling of the same number of targets from all target
mRNAs recovered in the BC-1 PAR-CLIP library (Supplemental
Experimental Procedures). Consequently, it appears that the
KSHV and EBV miRNAs have independently evolved to share
many targets and therefore may have overlapping functions,
despite the distinct seed sequences of the KSHV and EBVevier Inc.
Figure 5. Validation of PAR-CLIP Targets by 30UTR Indicator Assays
(A) Heat map summarizing 30UTR indicator data obtained with combinations of 30UTR indicators (columns) and miRNA expression vectors (rows) as indicated.
Expression ofmiR-K1 (YWHAB), miR-K8 (all other 30UTRs), or seedmutantmiR-K11 served as negative controls. Other than controls, 37 interactions were tested,
all predicted by PAR-CLIP, with the exception of CDKN1B/miR-K11. Black boxes mark mRNAs that were downregulated in microarray data. Regulation
was statistically significant (p < 0.05, nR 3), except where indicated by green boxes. Empty boxes, not tested.
(B) The miR-K1 seed match in the 30UTR of RFXAP was inactivated by mutation (CTGTAA to CAGTTA).
(C) The seed match to miR-K9-3p in the 30UTR of ZFYVE9 was inactivated by mutation (TACCCA to TTCCGA).
(D–G) Seed matches to miR-K10/miR-142-3p in the ZFYVE9 (D), SOS1 (E), CTNND1 (F), and CDKN1B (G) 30UTRs were inactivated (ACACTA to AGACAA)
alone (M, M1, M2) or in combination (DM).
(H) Additional miR-K10 candidate targets were tested for regulation by miR-142-3p. Expression of miR-K8 served as negative control. All error bars represent
SD (nR 3). See also Figure S1.
(I) Overlap of mRNAs with 30UTR clusters assigned to seed variants of miR-K10 and miR-142-3p.
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Figure 6. Properties of KSHV miRNA Targets
(A) Selected pathways with significant enrichments of KSHV miRNA targets.
P values shownwere calculated against the background of the human genome
but remained significant (p < 0.05) when calculated against mRNAs expressed
in both PEL cell lines or transcripts with PAR-CLIP clusters.
(B) Selected pathways with significant enrichments of EBV miRNA targets.
P values were calculated against human genome, all pathways shown re-
mained significant when calculated against expressed mRNAs or transcripts
with PAR-CLIP clusters in BC-1 cells.
(C) Overlap of KSHV and EBV 30UTR target mRNAs with T to C conversions
at minimally two locations identified in BC-1. See also Table S8 and Table S12.
Cell Host & Microbe
PEL miRNA TargetomemiRNAs. However, validation of these interactions and func-
tional experiments will be required to confirm that this overlap
in PAR-CLIP targets indeed translates into significant functional
similarities. Similar functions of the KSHV and EBV miRNAs are
perhaps expected, given that KSHV and EBV share tropism for
B cells in vivo and have similar requirements for latent infection.
The large majority of the targets of either KSHV or EBVmiRNAs
were cellular mRNAs. However, several clusters with seed
matches to either viral and/or cellular miRNAs were detected in
the KSHV and EBV genomes (Table S6 and data not shown).
Because nearly all cells used for PAR-CLIP do not express the
KSHV transcripts characteristic of lytic replication, these clusters
were mostly located in mRNAs with known expression during
KSHV latency (Table S13). Clusters detected in both cell lines
included sites for miR-K10/miR-142-3p in the 30UTRs of vIL-6
and v-IRF3 as well as two clusters each for miR-K10/miR-142-
3p and let7 located within the mRNAs encoding the viral latent
proteins LANA, v-cyclin, and v-FLIP. The functional significance
of these sites remains unknown. We did not detect evidence of
any of the reported interactionswith lytic mRNAs (Bellare andGa-
nem, 2009; Lin and Ganem, 2011), but such interactions might
havebeenmisseddue to thevery lowabundanceof thesemRNAs.524 Cell Host & Microbe 10, 515–526, November 17, 2011 ª2011 ElsDISCUSSION
During latency, KSHV expresses few proteins but multiple viral
miRNAs. While a substantial amount of work has addressed the
role of the latent proteins, the functions of KSHV-encoded
miRNAs remain largely unknown.Herewe report the comprehen-
sive identification of miRNA target sites of all significantly
expressed miRNAs in EBV-negative and EBV-positive PEL cell
lines. The resulting data set confirmed many interactions with
known functional relevance and identified KSHV miRNA binding
sites in >2000 candidate targets of the KSHV miRNAs. Based
on the recovery of published targets, we estimate that our data
set identifies minimally 40% of canonical 30UTR targets of the
KSHV miRNAs in B cells. We believe this estimate to be conser-
vative, because many published interactions are supported by
onlyminimal evidence andmay therefore prove to be false.More-
over, not every possible interaction is expected to occur in every
cellular context. Assuming that at least a subset of the binding
sites found in coding regions are functional and that KSHV
miRNAs may also engage in some interactions that are not
dependent on perfect seed base pairing, the actual number of
cellular binding sites forKSHVmiRNAswill certainly reach several
thousand. Consequently, it appears that the KSHVmiRNAs have
evolved a highly complex regulatory network with the human
transcriptome. Despite this, it also remains possible that only
a relatively small subset of these interactions provide a strong
selective advantage to KSHV, while many other interactions
could be largely inconsequential to KSHV biology. Such particu-
larly important targets could include those with multiple KSHV
miRNA binding sites, for example CDKN1A (p21) or Wee1.
This report identifies targets of viral miRNAs at sufficient depth
to allow meaningful pathway analysis, which revealed a number
of pathways that are likely to be regulated by these miRNAs.
These included transcriptional regulation, signal transduction,
vesicular trafficking, and the regulation of cell cycle and
apoptosis. Interestingly, we found that 58% of genes targeted
by KSHV miRNAs were also bound by EBV miRNAs. Because
KSHV and EBV have a similar biology, this observation may
help to identify targets of key importance to these viruses. It is
important to point out that PAR-CLIP merely captures interac-
tions, including those that may be transient or may not result in
functionally relevant levels of regulation (see above and the
Supplemental Discussion). Thus, this manuscript is intended
to provide a resource for further validation and functional inves-
tigation. Clearly, loss-of-function experiments in the context of
the virus and gain-of-function experiments with ectopically ex-
pressed miRNAs will be needed to validate the inhibitory effect
of the KSHV miRNAs on individual targets and on the pathways
listed in this manuscript.
Finally, our data revealed that KSHV encodes miRNAs that
mimic the function of two hematopoietic microRNAs, miR-155
and miR-142-3p. Because miR-142-3p is likely expressed in
lymphoid targets of KSHV, miR-K10a may have evolved to over-
express one of the miR-142-3p seeds in B cells and thus enforce
the repression of a subset of miR-142-3p targets. Alternatively,
miR-K10a may mimic a subset of miR-142-3p functions in cell
types lacking endogenous miR-142 expression, including endo-
thelial cells. The observation that miR-142-3p and miR-K10
interact with a number of latent transcripts also raises theevier Inc.
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tune latent gene expression in lymphoid cells.
EXPERIMENTAL PROCEDURES
Small RNA and PAR-CLIP Library Construction and Bioinformatics
Analysis
Small RNA and PAR-CLIP libraries were constructed as described (Hafner et al.,
2010; Umbach and Cullen, 2010). Resulting reads were preprocessed using the
FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) and aligned to the
human, KSHV, and/or EBV genomes using Bowtie (Langmead et al., 2009).
PAR-CLIP libraries were prepared as described (Hafner et al., 2010). For PAR-
CLIP, 1.5 3 109 BC-3 cells and 3 3 109 BC-1 cells were labeled with
100 mM 4-Thiouridine (4SU, Sigma) for 18 hr. At the time of harvest, cells
were at or below 106 cells/ml. PAR-CLIP data were analyzed using PARalyzer,
with slightly different mapping parameters (Corcoran et al., 2011). Briefly, we
employed a low stringency mapping strategy, allowing up to three mismatches
per read to maximize the number of unique sites. Reads of at least 13 nt were
kept if they mapped to a unique location after discounting T to C mismatches.
Consecutive nucleotideswith higher likelihood of T toC conversion thannoncon-
version and a readdepth of at least 5 are considered ‘‘interaction sites’’ andwere
extended to clusters, which include all adjacent positions with a read depth of at
least 5. Clusters were searched for miRNA seed matches to all miRNAs with
significant expression in the matched small RNA sequencing samples. Seed
matches were designated according to standard nomenclature (Bartel, 2009):
forexample, ‘‘7mer1A’’ seedmatches,nucleotides2–7of themiRNAareperfectly
base paired with the target and the match is followed by an A in the 30UTR. For
example, ‘‘7mer2-8’’ seed matches, nucleotides 2–8 of the miRNA are perfectly
base paired.We designated different seed types for up to 12-mer seedmatches.
Seed matches that were more extensive were also designated as ‘‘12mer’’ seed
matches. Next generation sequencing data were submitted to GEO (GSE32113)
and the complete, analyzed small RNA, and PAR-CLIP data sets can be down-
loaded from http://bugs.mimnet.northwestern.edu/labs/gottweinlab/index.html.
Plasmids
Plasmids were either previously reported or based on the previously published
vectors pLCE, for miRNA expression, and pLSG/pLSR for 30UTR indicator
expression (Gottwein and Cullen, 2010; Gottwein et al., 2007; Zhang et al.,
2009). Detailed cloning procedures can be found in the Supplemental Exper-
imental Procedures.
Cell Lines, Microarrays, and Cell-Based Assays
All cell lines were cultured as previously described (Gottwein and Cullen, 2010;
Gottwein et al., 2007). BC-1 and BC-3 cells were from ATCC, other PEL cell
lines were obtained from Dirk Dittmer (UNC), with permission from the original
investigators. Lentivirally transduced BJAB cell pools expressing miR-K1,
miR-K4-3p, or miR-K11 were described previously or generated as described
using published constructs (Gottwein et al., 2007).Microarray analysis of BJAB
cell pools was performed on Human Operon v3.0.2 arrays as described for
miR-K11 (Gottwein et al., 2007).Microarray analysis of BC-1 andBC-3 cell lines
was done on Affymetrix Gene 1.0 ST arrays. Indicator assays, primer extension
analyses, and western blotting were carried out as described previously (Gott-
wein and Cullen, 2010; Gottwein et al., 2007) with modifications detailed in
the Supplemental Experimental Procedures. Primary antibodies specific for
TPD52 (1:500, antibody H-45, sc-67063) and GAPDH (1:5000, antibody 0411,
sc-47724) were from Santa Cruz, primary antibody for PPP2CA (1:1000, anti-
body 52F8, catalog number 2259) was from Cell Signaling Technologies.
ACCESSION NUMBERS
Microarray and Illumina Sequencing data were submitted to the Gene Expres-
sion Omnibus under accession number GSE32113.
SUPPLEMENTAL INFORMATION
Supplemental Information includes 1 figure, 13 tables, Supplemental Discus-
sion, Supplemental Experimental Procedures, and Supplemental References
and can be found with this article online at doi:10.1016/j.chom.2011.09.012.Cell Host &ACKNOWLEDGMENTS
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